ICAM2 and rheumatoid arthritis: Intraperitoneal injection of artemisitene in an RA mouse model inhibits METTL3, which in turn reduces the expression of ICAM2 mRNA, ultimately preventing the migration and invasion of RA-FLSs and inducing apoptosis 121.